SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-18-000840
Filing Date
2018-10-25
Accepted
2018-10-25 17:16:58
Documents
2
Group Members
ORBIMED CAPITAL GP III LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss112224_sc13da.htm SC 13D/A 129359
2 JOINT FILING AGREEMENT ss112224_9901.htm EX-99.1 14621
  Complete submission text file 0000947871-18-000840.txt   145467
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Subject) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89550 | Film No.: 181139682
SIC: 2834 Pharmaceutical Preparations